We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QCRH:NASDAQQCR Holdings, Inc. Analysis

Data as of 2026-05-29 - not real-time

$91.38

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

QCR Holdings posted a strong Q1 with revenue up over 20% year‑over‑year and net income climbing more than 30% versus the prior year, comfortably beating analyst expectations. Operating margins near 44% and a profit margin above 35% underscore the bank’s efficient cost structure. The stock is trading above its 20‑day and 50‑day moving averages while the MACD line sits above the signal line, delivering a bullish technical signal, and the RSI hovers in the neutral zone, suggesting room for upside without immediate overbought pressure. Support sits just below the current price, and resistance lies a few dollars higher, framing a tight trading range that aligns with the recent price rally. A beta slightly below one points to modest volatility relative to the broader market, and the 30‑day volatility reading indicates a moderate price swing. The price‑to‑earnings multiple is well under the industry average, and the price‑to‑book ratio remains modest, reinforcing a value‑oriented appeal. The discounted cash‑flow model projects a fair value far above the market price, implying roughly a ten percent upside potential. Dividend yield sits at less than half a percent, but the payout ratio is extremely low, making the distribution highly sustainable given the strong cash balance. Overall, the combination of robust earnings, attractive valuation multiples, and supportive technicals makes the stock a compelling candidate for investors seeking a blend of growth and value in a regional banking play.
Given the recent earnings beat, solid balance sheet, and favorable technical backdrop, the short‑term outlook is positive, while the long‑term narrative is reinforced by consistent profitability and a disciplined dividend policy.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover
  • Recent earnings beat
  • Support level just below current price

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation multiples
  • Strong operating margins
  • Sustainable dividend with low payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent revenue growth
  • Robust cash position versus debt
  • Blend of growth and value characteristics

Key Metrics & Analysis

Financial Health

Revenue Growth21.10%
Profit Margin36.75%
P/E Ratio11.5
ROE12.57%
ROA1.44%
P/B Ratio1.3
Op. Cash Flow$429.5M
Industry P/E16.5

Technical Analysis

TrendBullish
RSI55.4
Support$86.56
Resistance$93.70
MA 20$90.33
MA 50$88.81
MA 200$83.35
MACDBullish
VolumeDecreasing
Fear & Greed Index93.38

Valuation

Fair Value$557.85
Target Price$100.40
Upside/Downside9.87%
GradeUndervalued
TypeBlend
Dividend Yield0.44%

Risk Assessment

Beta0.93
Volatility22.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.